Timothy J. Sangiovanni, the SVP of $ZVRA, sold 1,750 shares of the company on 01-30-2026 for an estimated $15,442. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.7% of their shares of this class of stock. Following this trade, they now own 20,924 shares of this class of $ZVRA stock.
$ZVRA Insider Trading Activity
$ZVRA insiders have traded $ZVRA stock on the open market 9 times in the past 6 months. Of those trades, 3 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $ZVRA stock by insiders over the last 6 months:
- NEIL F. MCFARLANE (President and CEO) has made 0 purchases and 2 sales selling 110,500 shares for an estimated $1,064,333.
- ALVIN SHIH purchased 20,000 shares for an estimated $157,800
- JOHN B BODE purchased 5,000 shares for an estimated $45,824
- ADRIAN W QUARTEL (Chief Medical Officer) sold 4,533 shares for an estimated $40,035
- RAHSAAN THOMPSON (Chief Legal & Compliance) sold 4,080 shares for an estimated $36,009
- JOSHUA SCHAFER (CCO) sold 3,375 shares for an estimated $29,800
- TAMARA A FAVORITO purchased 3,175 shares for an estimated $24,718
- TIMOTHY J. SANGIOVANNI (SVP, Finance & Corp Controller) sold 1,750 shares for an estimated $15,442
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ZVRA Hedge Fund Activity
We have seen 106 institutional investors add shares of $ZVRA stock to their portfolio, and 52 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RUBRIC CAPITAL MANAGEMENT LP removed 1,958,318 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $18,623,604
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,943,000 shares (-46.6%) from their portfolio in Q3 2025, for an estimated $18,477,930
- ALTIUM CAPITAL MANAGEMENT LLC removed 1,287,333 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $12,242,536
- AIGH CAPITAL MANAGEMENT LLC removed 1,231,932 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $11,038,110
- WOODLINE PARTNERS LP removed 1,139,533 shares (-24.7%) from their portfolio in Q3 2025, for an estimated $10,836,958
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,044,021 shares (+646.5%) to their portfolio in Q3 2025, for an estimated $9,928,639
- MARSHALL WACE, LLP added 912,299 shares (+inf%) to their portfolio in Q3 2025, for an estimated $8,675,963
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ZVRA Revenue
$ZVRA had revenues of $26.1M in Q3 2025. This is an increase of 605.36% from the same period in the prior year.
You can track ZVRA financials on Quiver Quantitative's ZVRA stock page.
$ZVRA Analyst Ratings
Wall Street analysts have issued reports on $ZVRA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 11/06/2025
- JMP Securities issued a "Market Outperform" rating on 08/13/2025
To track analyst ratings and price targets for $ZVRA, check out Quiver Quantitative's $ZVRA forecast page.
$ZVRA Price Targets
Multiple analysts have issued price targets for $ZVRA recently. We have seen 3 analysts offer price targets for $ZVRA in the last 6 months, with a median target of $24.0.
Here are some recent targets:
- Sumant Kulkarni from Canaccord Genuity set a target price of $24.0 on 11/06/2025
- Kristen Kluska from Cantor Fitzgerald set a target price of $24.0 on 11/06/2025
- Jason N. Butler from JMP Securities set a target price of $18.0 on 08/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
